• search

Wockhardt gets US FDA approval for Cefotaxime injection

Written by: Staff
|

Mumbai, Aug 31 (UNI) Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food&Drug Administration (US FDA) for marketing Cefotaxime sodium (1 gm) injection in the US market. Cefotaxime Sodium is the generic version of Sanofi Aventis' Claforan antibiotic injection used in treating a wide variety of infections.

''This is our second approval for sterile cephalosporins, and our sixth approval in the last eight months,'' said Wockhardt Chairman Habil Khorakiwala. ''The rapid build-up of portfolio is helping us make our presence felt in the US, world's largest pharmaceutical market.'' Wockhardt's US subsidiary, Wockhardt USA Inc., will launch this cephalosporin antibiotic in the US market within the next few weeks, a company release said.

Cefotaxime sodium is manufactured at the US FDA certified sterile cephalosporin API (active pharmaceutical ingredient) facility at Ankleshwar and the injection is manufactured at the sterile formulation plant at Waluj. The processes for both API and the injection were developed in-house, the release added.

UNI AR GB AG1619

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more